Logo image of PRCT

PROCEPT BIOROBOTICS CORP (PRCT) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:PRCT - US74276L1052 - Common Stock

32.41 USD
-0.47 (-1.43%)
Last: 12/26/2025, 8:10:39 PM
32.41 USD
0 (0%)
After Hours: 12/26/2025, 8:10:39 PM
Buy % Consensus

84

ChartMill assigns a Buy % Consensus number of 84% to PRCT. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 53.81. This target is 66.01% above the current price.
PRCT was analyzed by 19 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about PRCT.
In the previous month the buy percentage consensus was at a similar level.
PRCT was analyzed by 19 analysts, which is quite many. So the average rating should be quite meaningful.
PRCT Historical Analyst RatingsPRCT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -49 -44 -39 -34 -29 -24 -19 -14 -9 -4 5 10 15

Price Target & Forecast

Price Low Median Mean High 32.4138.3852.0253.8178.75 - 18.42% 60.51% 66.01% 142.98%
PRCT Current Analyst RatingPRCT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8
Up and Down Grades
Date Firm Action Rating
2025-12-18 Truist Securities Maintains Buy -> Buy
2025-12-12 UBS Initiate Buy
2025-12-08 B of A Securities Downgrade Buy -> Neutral
2025-12-02 Morgan Stanley Maintains Overweight -> Overweight
2025-11-05 TD Cowen Maintains Buy -> Buy
2025-11-05 Wells Fargo Maintains Overweight -> Overweight
2025-11-05 Piper Sandler Reiterate Overweight -> Overweight
2025-10-15 Truist Securities Maintains Buy -> Buy
2025-09-16 BTIG Reiterate Neutral -> Neutral
2025-09-02 Oppenheimer Upgrade Perform -> Outperform
2025-08-07 Wells Fargo Maintains Overweight -> Overweight
2025-08-07 Piper Sandler Maintains Overweight -> Overweight
2025-07-15 Morgan Stanley Maintains Overweight -> Overweight
2025-07-07 Oppenheimer Initiate Perform
2025-04-25 B of A Securities Maintains Buy -> Buy
2025-04-11 Truist Securities Maintains Buy -> Buy
2025-02-26 Truist Securities Reiterate Buy -> Buy
2025-02-26 Morgan Stanley Maintains Overweight -> Overweight
2024-12-03 Wells Fargo Reiterate Overweight -> Overweight
2024-12-02 Morgan Stanley Initiate Overweight
2024-11-14 Jefferies Initiate Hold
2024-10-30 Truist Securities Reiterate Buy -> Buy
2024-10-08 Piper Sandler Reiterate Overweight -> Overweight
2024-09-16 TD Cowen Maintains Buy -> Buy
2024-09-03 Truist Securities Maintains Buy -> Buy
2024-08-22 B of A Securities Maintains Buy -> Buy
2024-08-02 Wells Fargo Maintains Overweight -> Overweight
2024-08-02 Truist Securities Reiterate Buy -> Buy
2024-07-16 Truist Securities Maintains Buy -> Buy
2024-05-06 TD Cowen Maintains Buy -> Buy

PROCEPT BIOROBOTICS CORP / PRCT FAQ

What is the price target for PRCT stock?

19 analysts have analysed PRCT and the average price target is 53.81 USD. This implies a price increase of 66.01% is expected in the next year compared to the current price of 32.41.


What is the consensus rating for PROCEPT BIOROBOTICS CORP (PRCT) stock?

The consensus rating for PROCEPT BIOROBOTICS CORP (PRCT) is 84.2105 / 100 . This indicates that analysts generally have a positive outlook on the stock.


How many analysts cover PROCEPT BIOROBOTICS CORP (PRCT) stock?

The number of analysts covering PROCEPT BIOROBOTICS CORP (PRCT) is 19.